English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Novartis
Ruth de Jauregui
| Jun 7, 2017
Bristol-Myers Squibb, Novartis to study combination treatment for colorectal cancer
Erianne Leatherman
| Jun 6, 2017
Novartis highlighting cancer care data at national, international forums
Erianne Leatherman
| Jun 6, 2017
Zykadia under consideration in Europe for expanded use to treat non-small cell lung cancer
Robert Hadley
| Jun 3, 2017
FDA OKs Novartis' Zykadia for metastatic lung cancer affecting the brain
Robert Hadley
| May 28, 2017
Bronchodilators equal corticosteroids for COPD use, Novartis study claims
Ruth de Jauregui
| May 21, 2017
Novartis Foundation announces new initiative on World Hypertension Day
Robert Hadley
| May 3, 2017
Clinical trial results offer hope for multiple sclerosis sufferers
Erianne Leatherman
| Apr 30, 2017
Amgen, Novartis broaden partnership for erenumab
Trending
+
Regulatory
C.D. Marsden
| Apr 12, 2025
Empower Pharmacy: Eli Lilly lawsuit is ‘Big Pharma’s attempt to limit patient and provider choice’
+
Community
Patient Daily
| Apr 17, 2025
ENT Practice Expert: OTO Forum 2025 will feature 'at least four topics that stand out as vital for doctors'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
UCSF neurosurgeon: '340B is a drug discount program that hospitals exploit as an additional revenue stream'
+
Pharmaceuticals
Patient Daily
| Apr 15, 2025
President of Drug Channels Institute: 'Hospital prices are significantly higher at large 340B hospitals'
« First
«
1
2
3
»
Last »